Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Queensland Health
Accenture
UBS
Mallinckrodt
Chubb
Cerilliant
Colorcon

Generated: July 22, 2018

DrugPatentWatch Database Preview

Iothalamate sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for iothalamate sodium and what is the scope of iothalamate sodium freedom to operate?

Iothalamate sodium
is the generic ingredient in four branded drugs marketed by Mallinckrodt and Isotex, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for iothalamate sodium.
Summary for iothalamate sodium
Synonyms for iothalamate sodium
1225-20-3
2276-90-6 (Parent)
5-Acetylamino-N-methyl-2,4,6-triiodoisophthalamic acid sodium salt
AN-22363
Angio-Conray
Angio-contrix
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo- 5-[(methylamino)carbonyl]-, monosodium salt
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, monosodium salt
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]-, monosodium salt
CAS-1225-20-3
CHEMBL1097620
Conray 300
Conray 325
Conray 400
Conray 400 (TN)
Conray 80
Conray-400
D02KCV
D03603
DR003422
DSSTox_CID_31457
DSSTox_GSID_57668
DSSTox_RID_97343
DTXSID1057668
EINECS 214-955-8
Iotalamate de sodium
Iotalamate de sodium [French]
Iothalamate sodium (injection)
Iothalamate sodium (USP)
Iothalamate Sodium [USAN]
Iothalamate sodium [USP]
Iothalamate sodium salt
Iothalamic acid sodium salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, monosodium salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, sodium salt
ISOPHTHALAMIC ACID, 5-ACETYLAMINO-N-METHYL-2,4,6-TRIIODO-, SODIUM SALT
KDN276D83N
LS-85186
Mediocontrix
Monosodium 5-acetamido-2,4,6-triiodo-N-methylisophthalamate
NCGC00253600-01
OR209625
OR209626
SCHEMBL159919
Sodium 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
SODIUM 3-(ACETYLAMINO)-2,4,6-TRIIODO-5-[(METHYLAMINO)CARBONYL]BENZOATE
sodium 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
Sodium iotalamate
SODIUM IOTALAMATE (131 I)
Sodium iotalamate injection
Sodium iotalamate injection (JP17)
Sodium iothalamate
Tox21_113735
UNII-KDN276D83N
WCIMWHNSWLLELS-UHFFFAOYSA-M

US Patents and Regulatory Information for iothalamate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt CONRAY 400 iothalamate sodium INJECTABLE;INJECTION 014295-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinckrodt CONRAY 325 iothalamate sodium INJECTABLE;INJECTION 017685-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Isotex GLOFIL-125 iothalamate sodium i-125 INJECTABLE;INJECTION 017279-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinckrodt ANGIO-CONRAY iothalamate sodium INJECTABLE;INJECTION 013319-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Chinese Patent Office
Express Scripts
QuintilesIMS
Harvard Business School
US Department of Justice
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.